About Translational & Correlative Services
The Translational and Correlative Services (TCS) of the Global Center for Immunotherapy and Precision Immuno-Oncology (CITI) comprises three state-of-the-art, fee-for-service platforms. These shared services provide harmonized services spanning sample processing for clinical samples, advanced genomics analysis, immunologic interrogation, and much more. We offer cutting-edge technologies for immuno-oncology, immunology, genomics and other research areas. TCS collaborates with scientists, clinicians, and industry partners involved in clinical trials and discovery-based immunologic and cancer research to provide expansive end-to-end solutions for diverse research needs.
The Immunomonitoring Laboratory (IML) provides cutting-edge technology platforms for the comprehensive immuno-profiling and -phenotyping of patient biospecimen.
The Discovery Laboratory offers state-of-the-art high-throughput technologies, immunologic testing, and next generation sequencing (NGS)-based platforms.
The Computational Oncology Platform uses various computational technologies for processing, analysis, and visualization of high-throughput data.